Shandong Sanyuan Biotechnology Co.Ltd. (301206) — Cash Flow-to-Debt Ratio
Shandong Sanyuan Biotechnology Co.Ltd. (301206) has a Cash Flow-to-Debt Ratio of 0.15x as of September 2025, meaning its operating cash flow of CN¥24.79 Million could theoretically repay 0% of its total liabilities (CN¥166.97 Million) in one year. See Shandong Sanyuan Biotechnology Co.Ltd. free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shandong Sanyuan Biotechnology Co.Ltd. Cash Flow-to-Debt Ratio (2013–2024)
Historical debt coverage capacity for Shandong Sanyuan Biotechnology Co.Ltd. across 12 annual periods. Also explore how fast is Shandong Sanyuan Biotechnology Co.Ltd. growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Shandong Sanyuan Biotechnology Co.Ltd. (2013–2024)
Year-by-year debt coverage analysis for Shandong Sanyuan Biotechnology Co.Ltd.. For market capitalisation and broader financial context, see market value of Shandong Sanyuan Biotechnology Co.Ltd..
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.04x | CN¥-13.65 Million | CN¥314.04 Million | ▼ -120.7% |
| 2023 | 0.21x | CN¥57.31 Million | CN¥272.40 Million | ▼ -37.8% |
| 2022 | 0.34x | CN¥84.26 Million | CN¥249.14 Million | ▼ -69.0% |
| 2021 | 1.09x | CN¥642.08 Million | CN¥588.83 Million | ▲ +36.2% |
| 2020 | 0.80x | CN¥217.37 Million | CN¥271.48 Million | ▼ -5.8% |
| 2019 | 0.85x | CN¥149.21 Million | CN¥175.59 Million | ▲ +30.0% |
| 2018 | 0.65x | CN¥65.46 Million | CN¥100.12 Million | ▲ +110.9% |
| 2017 | 0.31x | CN¥20.25 Million | CN¥65.31 Million | ▼ -45.4% |
| 2016 | 0.57x | CN¥22.96 Million | CN¥40.44 Million | ▲ +47.3% |
| 2015 | 0.39x | CN¥9.50 Million | CN¥24.64 Million | ▲ +270.0% |
| 2014 | 0.10x | CN¥3.20 Million | CN¥30.68 Million | ▼ -48.8% |
| 2013 | 0.20x | CN¥3.89 Million | CN¥19.10 Million | — |